| 1N1L | A:29-94; B:29-94 | CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND INHIBITOR (GW472467X) |
| 1RTL | A:1-94; B:29-94 | CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN: NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND PYRROLIDINE-5,5-TRANSLACTAM INHIBITOR |
| 2O8M | A:-3-94; B:29-94 | CRYSTAL STRUCTURE OF THE S139A MUTANT OF HEPATITIS C VIRUS NS3/4A PROTEASE |
| 2OBO | A:-1-94; C:29-94 | STRUCTURE OF HEPATITIS C VIRAL NS3 PROTEASE DOMAIN COMPLEXED WITH NS4A PEPTIDE AND KETOAMIDE SCH476776 |
| 2OBQ | A:1-94; C:29-94 | DISCOVERY OF THE HCV NS3/4A PROTEASE INHIBITOR SCH503034. KEY STEPS IN STRUCTURE-BASED OPTIMIZATION |
| 2OC0 | A:1-94; C:29-94 | STRUCTURE OF NS3 COMPLEXED WITH A KETOAMIDE INHIBITOR SCH491762 |
| 2OC7 | A:1-94; C:29-94 | STRUCTURE OF HEPATITIS C VIRAL NS3 PROTEASE DOMAIN COMPLEXED WITH NS4A PEPTIDE AND KETOAMIDE SCH571696 |
| 2OC8 | A:-1-94; C:29-94 | STRUCTURE OF HEPATITIS C VIRAL NS3 PROTEASE DOMAIN COMPLEXED WITH NS4A PEPTIDE AND KETOAMIDE SCH503034 |
)
)